Salvatore Privitera

Salvatore Privitera is a declared insider of AtriCure, Inc. (senior executive), with filings sourced from SEC (Form 4). The record holds 48 filings, for trades running from 24 July 2017 to 23 September 2026.

In open-market terms, that means 1 purchase worth €103k on one side and 8 sales worth €2.7M on the other. Taken together, the sales exceed the purchases by €2.6M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 39 share grants. Since January 2026: no purchases and 3 sales on the market.

The record was last updated on 24 September 2026 with an open-market sale (€237k) in AtriCure, Inc. The last insider purchase was made public on 31 May 2024, 876 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.